Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Florham Park, New Jersey
- Most recent report
- 10-K/A, filed Oct 20, 2026
- Incorporated
- Delaware
- Filings on record
- 557 filings
- On EDGAR
- CIK 1752828
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8 of 32
News 8 of 122
- 8-K Leadership change Sep 29, 2026
- 8-K Leadership change Sep 28, 2026
- 8-K Other events Sep 14, 2026
- 8-K Leadership change Aug 7, 2026
- 8-K Current report on a material event Jul 29, 2026
- 8-K Leadership change Jun 30, 2026
- 8-K Leadership change Jun 25, 2026
- 8-K Current report on a material event Jun 12, 2026
Prospectuses and Registrations 8 of 64
- 25-NSE Notice that a security was delisted Jul 22, 2026
- 424B3 Prospectus supplement for an offering Jan 8, 2026
- S-1 Registration statement for an offering Dec 31, 2025
- 424B3 Prospectus supplement for an offering Dec 30, 2025
- S-1 Registration statement for an offering Dec 19, 2025
- S-8 Registration statement for an employee plan Nov 7, 2025
- FWP Free writing prospectus Feb 13, 2025
- S-1/A Registration statement for an offering, amended Feb 13, 2025
Proxies 8 of 13
- DEFA14A Extra proxy material Nov 7, 2025
- DEF 14A Proxy statement for a shareholder vote Nov 7, 2025
- DEF 14A Proxy statement for a shareholder vote Nov 19, 2024
- DEF 14A Proxy statement for a shareholder vote Feb 2, 2024
- PRE 14A Preliminary proxy statement Jan 23, 2024
- DEF 14A Proxy statement for a shareholder vote May 1, 2023
- PRE 14A Preliminary proxy statement Apr 21, 2023
- DEF 14A Proxy statement for a shareholder vote Jun 3, 2022
Ownership 8 of 237
- SCHEDULE 13D/A Large holder reported an active stake, amended Sep 28, 2026
- 4 Insider reported a trade Sep 25, 2026
- 4 Insider reported a trade Sep 25, 2026
- 4 Insider reported a trade Sep 25, 2026
- 4 Insider reported a trade Jun 23, 2026
- 4 Insider reported a trade Jun 23, 2026
- 4 Insider reported a trade Jun 23, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Jun 23, 2026
Other 8 of 89
- NT 10-Q Notice that a quarterly report will be late Aug 14, 2026
- NT 10-Q Notice that a quarterly report will be late May 15, 2026
- NT 10-K Notice that an annual report will be late Mar 31, 2026
- EFFECT Notice that a registration became effective Jan 7, 2026
- CORRESP Reply to SEC staff Jan 5, 2026
- UPLOAD Comment letter from SEC staff Jan 5, 2026
- EFFECT Notice that a registration became effective Dec 29, 2025
- CORRESP Reply to SEC staff Dec 23, 2025
Everything here comes from Celularity Inc's own filings on SEC EDGAR. The filing list is rechecked every hour.